Successful Returns Management Starts With An Effective Returns Policy

Inmar Intelligence Healthcare Team | February 21, 2024


Exclusively for Pharmaceutical Manufacturers

Establishing a clear and consistent returns policy is an absolute requirement for any drug- or device-maker committed to successfully mitigating the financial liability attached to product flowing back through the supply chain.

However, creating a returns policy that protects profitability while positioning the manufacturer as a collaborative and valued trading partner demands close attention to a number of core considerations.

This white paper explores these core considerations, as well as key outlying factors, and delivers additional insight into building an effective returns policy by examining common healthcare industry practices related to accepting returns and issuing credit.

Download our white paper to learn which factors are shaping Rx returns policy across the industry.